Serum metabolomics identified specific lipid compounds which may serve as markers of disease progression in patients with Alström and Bardet-Biedl syndromes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum metabolomics identified specific lipid compounds which may serve as markers of disease progression in patients with Alström and Bardet-Biedl syndromes
Authors
Keywords
-
Journal
Frontiers in Molecular Biosciences
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-11-07
DOI
10.3389/fmolb.2023.1251905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts
- (2023) Mengya Shi et al. Cardiovascular Diabetology
- Quantitative Lipidomic Analysis of Serum Phospholipids Reveals Dissociable Markers of Alzheimer’s Disease and Subcortical Cerebrovascular Disease
- (2023) Yurika Otoki et al. JOURNAL OF ALZHEIMERS DISEASE
- Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration
- (2023) Sara Xue et al. JOURNAL OF NEUROSCIENCE
- Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes
- (2023) Lidia Sojo et al. Antioxidants
- Metabolic signatures of insulin resistance in non-diabetic individuals
- (2022) Babak Arjmand et al. BMC Endocrine Disorders
- Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells
- (2022) Emanuela Marchese et al. iScience
- Identification of bone metabolism disorders in patients with Alström and Bardet-Biedl syndromes based on markers of bone turnover and mandibular atrophy
- (2022) Krzysztof Jeziorny et al. Bone Reports
- Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia
- (2021) Yifei Dong et al. NATURE NEUROSCIENCE
- Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
- (2020) Robert Haws et al. DIABETES OBESITY & METABOLISM
- Consensus clinical management guidelines for Alström syndrome
- (2020) Natascia Tahani et al. Orphanet Journal of Rare Diseases
- Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn’s Disease and Ulcerative Colitis—A Preliminary Study
- (2019) Urszula Daniluk et al. INFLAMMATORY BOWEL DISEASES
- Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes
- (2019) Maria F. Lopes-Virella et al. Journal of Clinical Lipidology
- Proteomics and metabolomics studies exploring the pathophysiology of renal dysfunction in autosomal dominant polycystic kidney disease and other ciliopathies
- (2019) Miriam Zacchia et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity
- (2019) Yang Wang et al. Biomed Research International
- Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity
- (2018) Jacqueline E. Siljee et al. NATURE GENETICS
- Managing Bardet–Biedl Syndrome—Now and in the Future
- (2018) Elizabeth Forsythe et al. Frontiers in Pediatrics
- Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: amino acid and acylcarnitine levels change along a spectrum of metabolic wellness
- (2018) Diane M. Libert et al. PeerJ
- Studies on diagnostic biomarkers and therapeutic mechanism of Alzheimer's disease through metabolomics and hippocampal proteomics
- (2017) Weiwei Lin et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Serum Metabolic Fingerprinting Identified Putatively Annotated Sphinganine Isomer as a Biomarker of Wolfram Syndrome
- (2017) Agnieszka Zmyslowska et al. JOURNAL OF PROTEOME RESEARCH
- Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort
- (2017) Marion Carayol et al. JOURNAL OF PROTEOME RESEARCH
- Cilia and Obesity
- (2017) Christian Vaisse et al. Cold Spring Harbor Perspectives in Biology
- Assessment of plasma acylcarnitines before and after weight loss in obese subjects
- (2016) Marieke G. Schooneman et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Bardet–Biedl syndrome: Genetics, molecular pathophysiology, and disease management
- (2016) Sathya Priya et al. INDIAN JOURNAL OF OPHTHALMOLOGY
- Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes
- (2016) Jennifer E. Ho et al. PLoS One
- Genetic evaluation of patients with Alström syndrome in the Polish population
- (2015) A. Zmyslowska et al. CLINICAL GENETICS
- Alström Syndrome: Mutation Spectrum ofALMS1
- (2015) Jan D. Marshall et al. HUMAN MUTATION
- A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome
- (2014) Zhi-rui Yu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Decreased plasma levels of select very long chain ceramide species Are associated with the development of nephropathy in type 1 diabetes
- (2014) Richard L. Klein et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Plasma Lipid Composition and Risk of Developing Cardiovascular Disease
- (2013) Celine Fernandez et al. PLoS One
- Alstrom Syndrome: Genetics and Clinical Overview
- (2012) Jan D. Marshall et al. CURRENT GENOMICS
- Acylcarnitines
- (2012) Marieke G. Schooneman et al. DIABETES
- Bardet–Biedl syndrome
- (2012) Elizabeth Forsythe et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Suppression of adipose lipolysis by long-chain fatty acid analogs
- (2012) Bella Kalderon et al. JOURNAL OF LIPID RESEARCH
- Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity
- (2010) Stephanie J. Mihalik et al. Obesity
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started